MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Viatris ROA Ratio 2011-2026 | VTRS
Annual ROA Ratio Viatris
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.45 | -1.53 | 0.11 | 4.16 | -2.31 | -1.09 | 0.05 | 1.08 | 1.94 | 1.38 | 3.81 | 5.85 | 4.09 | 5.37 | 4.63 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.85 | -9.45 | 1.21 |
Quarterly ROA Ratio Viatris
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.78 | -8.04 | -8.43 | -7.87 | 0.49 | 1.01 | 1.73 | 1.73 | 2.34 | 2.54 | 2.09 | 2.64 | 1.43 | -0.94 | -1.69 | -1.96 | -2.52 | -1.76 | - | -0.27 | -0.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.64 | -8.43 | -1.26 |
ROA Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-30.55 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-1.84 | $ 5.59 | -0.27 % | $ 83 M | USA |
 |
HEXO Corp.
HEXO
|
-157.66 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-25.07 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-48.08 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-45.36 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-0.24 | $ 2.66 | -0.93 % | $ 1.02 B | Canada |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
-1.29 | $ 39.34 | 4.5 % | $ 1.45 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
6.18 | $ 2.38 | 1.71 % | $ 302 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 22.84 | -0.65 % | $ 1.06 B | USA |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.02 | 2.01 % | $ 110 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 1.15 | 5.4 % | $ 1.43 M | USA |
 |
Aurora Cannabis
ACB
|
0.19 | $ 3.17 | 4.11 % | $ 174 M | Canada |
 |
Solid Biosciences
SLDB
|
-74.97 | $ 7.39 | 3.5 % | $ 647 M | USA |
 |
Jupiter Wellness
JUPW
|
-166.41 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.14 | $ 1.06 | -0.47 % | $ 101 M | Canada |
 |
Tilray
TLRY
|
-33.73 | $ 5.11 | 2.51 % | $ 3.16 B | Canada |
 |
Evolus
EOLS
|
-22.86 | $ 6.66 | -1.04 % | $ 429 M | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.44 | 1.75 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
3.99 | $ 8.35 | 0.36 % | $ 447 M | USA |
 |
cbdMD
YCBD
|
-19.59 | $ 0.7 | 2.06 % | $ 2.82 M | USA |
 |
Veru
VERU
|
-76.17 | $ 3.13 | 4.33 % | $ 45.8 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-31.31 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
-11.38 | $ 23.49 | 0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-24.62 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
0.6 | $ 5.08 | 0.4 % | $ 1.88 B | Canada |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-61.05 | $ 6.81 | 2.33 % | $ 269 M | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-16.73 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-14.58 | $ 4.31 | 1.89 % | $ 215 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Zomedica Corp.
ZOM
|
-64.44 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-9.3 | $ 0.65 | 3.92 % | $ 23.4 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-10.28 | $ 0.74 | -0.15 % | $ 3.18 M |  China |
 |
TherapeuticsMD
TXMD
|
-1.51 | $ 2.29 | 4.09 % | $ 26.5 M | USA |